Past Events
May 11, 2026
Presentation: Phase 2 randomized, double-blind, placebo-controlled study to evaluate BHB/HRS-1893 in adults with symptomatic non-obstructive hypertrophic cardiomyopathy
Location
Barcelona, Spain
April 1, 2026
Virtual Fireside Chat
March 28, 2026
Presentation: Efficacy and Safety of BHB/HRS-1893 In Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From a 12-Week Phase 2 Study
Location
New Orleans, LA
